Search by Drug Name or NDC
NDC 71713-0203-02 Ranitidine 150 mg/1 Details
Ranitidine 150 mg/1
Ranitidine is a ORAL TABLET, COATED in the HUMAN OTC DRUG category. It is labeled and distributed by Thirty Madison Inc. The primary component is RANITIDINE HYDROCHLORIDE.
Product Information
NDC | 71713-0203 |
---|---|
Product ID | 71713-203_1972bfea-e7a8-9315-8cf1-e0470f90ee52 |
Associated GPIs | |
GCN Sequence Number | n/a |
GCN Sequence Number Description | n/a |
HIC3 | n/a |
HIC3 Description | n/a |
GCN | n/a |
HICL Sequence Number | n/a |
HICL Sequence Number Description | n/a |
Brand/Generic | n/a |
Proprietary Name | Ranitidine |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | Ranitidine |
Product Type | HUMAN OTC DRUG |
Dosage Form | TABLET, COATED |
Route | ORAL |
Active Ingredient Strength | 150 |
Active Ingredient Units | mg/1 |
Substance Name | RANITIDINE HYDROCHLORIDE |
Labeler Name | Thirty Madison Inc |
Pharmaceutical Class | Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC] |
DEA Schedule | n/a |
Marketing Category | ANDA |
Application Number | ANDA078192 |
Listing Certified Through | 2024-12-31 |
Package
NDC 71713-0203-02 (71713020302)
NDC Package Code | 71713-203-02 |
---|---|
Billing NDC | 71713020302 |
Package | 1 BOTTLE in 1 CARTON (71713-203-02) / 24 TABLET, COATED in 1 BOTTLE |
Marketing Start Date | 2019-05-31 |
NDC Exclude Flag | N |
Pricing Information | N/A |